| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |